Randomized trial of zileuton in patients with moderate asthma: Effect of reduced dosing frequency and amounts on pulmonary function and asthma symptoms

American Journal of Managed Care

Volumn 3, Issue 4, 1997, Pages 633-640

  DuBuske, Lawrence M ^a,d   Grossman, Jay ^b   Dubé, Louise M ^c   Swanson, Linda J ^c   Lancaster, James F ^c  

^a Allerg and Arthr Fam Treatm Ctr   (United States)

^b Allergy Care Consultants Ltd   (United States)

^c ABBOTT LABORATORIES   (United States)

^d NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG DERIVATIVE; HYDROXYUREA; LIPOXYGENASE INHIBITOR; RESPIRATORY TRACT AGENT; ZILEUTON;

ADOLESCENT; ADULT; AGED; ARTICLE; ASTHMA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG ADMINISTRATION; HEALTH INSURANCE; HUMAN; LUNG FUNCTION TEST; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; UNITED STATES;

ADOLESCENT; ADULT; AGED; ASTHMA; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; HUMANS; HYDROXYUREA; LIPOXYGENASE INHIBITORS; MANAGED CARE PROGRAMS; MIDDLE AGED; RESPIRATORY FUNCTION TESTS; RESPIRATORY SYSTEM AGENTS; UNITED STATES;

EID: 0031110457     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Henderson WR Jr. The role of leukotrienes in inflammation. Ann Intern Med 1994;121:684-697.
2. Weiss JN, Drazen JM, Coles N. Bronchoconstrictor effects of leukotriene C in humans. Science 1982; 216:196-198.
3. 4 and histamine in normal subjects. Thorax 1984;39:500-504.
4. Lewis RA, Austen KF, Soberman RJ. Leukotrienes and other products of the 5-lipoxygenase pathway. N Engl J Med 1990;323:645-655.
5. Israel E, Dermarkarian R, Rosenberg M, et al. The effects of a 5-lipoxygenase inhibitor on asthma induced by cold, dry air. N Engl J Med 1990;323:1740-1744.
6. Israel E, Rubin D, Kemp J, et al. The effect of inhibition of 5-lipoxygenase by zileuton in mild to moderate asthma. Ann Intern Med 1993;119:1059-1066.
7. Israel E, Cohn J, Dubè L, et al. Effect of treatment with zileuton, a 5-lipoxygenase inhibitor, in patients with asthma. JAMA 1996;275:931-936.
8. Liu MC, Dubé LM, Lancaster JF, et al. Acute and chronic effects of a 5-lipoxygenase inhibitor in asthma: A 6-month randomized multicenter trial. J Allergy Clin Immunol 1996;98:859-871.
9. Physicians' Desk Reference. 50th ed. Montvale NJ: Medical Economics Co.; 1996;996-998, 2011-2012.